Acalabrutinib Yields Long-Term Efficacy in a Pooled Analysis of Higher-Risk CLL
Treatment with acalabrutinib-based regimens led to long-term benefits in patients with higher-risk CLL, across all lines of therapy.
Source: onclive.com
Page 29 - Cll News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cll Today - Breaking & Trending Today
When Cancer Consumes My Mind
Finding out that some family members have the BRCA gene makes me worried for them regarding the prospect of cancer.
Source: curetoday.com
Risk Factors Could Inform BTK Inhibitor and Venetoclax Sequencing in CLL/SLL
Changchun Deng, MD, PhD, discusses factors to consider when sequencing covalent BTK inhibitors and venetoclax in patients with CLL/SLL.
Source: onclive.com
Goals of Treatment for Patients With CLL
Josie Montegaard, MSN, AGPCNP-BC, discusses the goals of treatment for patients with chronic lymphocytic leukemia and how they may vary depending on factors such as age, risk level, and symptoms.
Source: curetoday.com
A Cancer Drug That Impacted My Life for SLL
After reading a book about how Imbruvica was revolutionized for SLL and CLL, I now have a greater appreciation for the drugs I receive.
Source: curetoday.com